Schering Consumer Strategy: Switch Claritin OTC, Establish Clarinex By DTC
Executive Summary
Schering-Plough's planned over-the-counter switch for Claritin should help the company establish Clarinex as a prescription brand
You may also be interested in...
Antihistamine OTC Switch: WellPoint Will Not Sue If FDA Refuses Petition
WellPoint will not take legal action against FDA should the agency reject the health insurer's citizen petition to force an OTC switch of prescription low- and non-sedating antihistamines
Antihistamine OTC Switch: WellPoint Will Not Sue If FDA Refuses Petition
WellPoint will not take legal action against FDA should the agency reject the health insurer's citizen petition to force an OTC switch of prescription low- and non-sedating antihistamines
Allegra “Drives On” With Physician Campaign Ahead Of Claritin OTC Switch
Aventis will not change its marketing strategy for Allegra following the departure of Schering-Plough's Claritin from the prescription antihistamine market